Solutions for Preparative HPLC


Application – related notes
Isolation of impurities with preparative HPLC
Isolation and purification of radio-labeled drug metabolites from pre-clinical urine samples
Isolation and purification of drug candidate metabolites from human urine samples
Purification of enantiomers
Mass-based fraction collection of compound libraries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Purification of natural products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Protein purification and characterization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Technique – related notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16-51
Mass-based fraction collection with the Agilent 6110/6120 Quadrupole LC/MS system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Optimal configuration of a mass-based purification system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Mass-based fraction collection at high flow rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Optimization mass-based fraction collection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Optimum performance with the Agilent dual-loop autosampler. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Multiple injections in an isocratic purification experiment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Combined system for analytical and preparative work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Injection pump system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Recovery collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Mass-based fraction collection at higher flow rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Optimization of mass-based fraction collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Optimization of fraction collection in general . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
System optimization for highest recovery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Peak-based fraction collection on a third-party detector signal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Method scale-up and scale-up calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Preparative pump performance from 1 to 100 mL/min . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Remote data review for enhanced lab productivity
Purification strategies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50-65
Creating an optimized preparative method set based on a pre-preparative analytical run . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Development of a compound purification strategy for a medicinal chemistry group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Compound purification on a system equipped with mass-selective detector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Purification of compounds from non-baseline separated peaks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
Usage of up and down slope in peak-based fraction collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Possible errors when doing automated fraction re-analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Injection of high-concentration samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Walk-up access for increased productivity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Purification system valve applications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66-71
Recycle chromatography. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Alternating column regeneration in preparative HPLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Recovery collection and time-based fraction collection

Za odpiranje dokumenta
kliknite tukaj …

Comments are closed.

Politika zasebnosti
Chemass

Naša spletna stran uporablja piškotke za namene zagotavljanja boljše funkcionalnosti in uporabniške izkušnje ter štetja uporabnikov na spletnem mestu. Uporabljamo piškotke Google Analytics, izdane s strani Google inc.. Informacije so shranjene v piškotkih vašega brskalnika in služijo namenu prepoznavanja vaše izbire ter anonimnemu štetju katere Chemassove spletne vsebine so se vam zdele zanimive in ste si jih ogledali.

Uporabo piškotkov lahko prilagodite v nastavitvah spodaj.

Obvezno potrebni piškotki

Priporočamo, da Obvezno potrebne piškotke vedno dovolite, da lahko shranimo vaše nastavitve glede uporabe piškotkov.

Če to možnost onemogočite boste ob vsakem naslednjem obisku Chemassovih strani morali izbiro o piškotkih ponovno nastaviti.

Google Analytics

Spletna stran uporablja Google Analytics za zbiranje anonimnih informacij o številu obiskovalcev in obiskanih straneh.

Če ta piškotek aktivirate nam omogočite učinkovitejše zagotavljanje boljše funkcionalnosti in uporabniške izkušnje na Chemassovi spletni strani.